SWM
FBIO icon

SeaCrest Wealth Management’s Fortress Biotech FBIO Stock Holding History

SeaCrest Wealth Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,000
Closed -$17.3K – 672
2024
Q3 		$17.3K Buy
12,000
+1,000
+9% +$1.9K ﹤0.01% 648
2024
Q2 		$18.8K Buy
+11,000
New +$19.9K ﹤0.01% 610

Other funds holding FBIO

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SeaCrest Wealth Management's FBIO Position: Q4 2024 in Review

SeaCrest Wealth Management sold out of Fortress Biotech (FBIO) in Q4 2024, closing a stake of 12,000 shares — an estimated $17.3K sold.

SeaCrest Wealth Management first reported a position in FBIO in Q2 2024 and held it in 2 quarters. The position peaked at $18.8K in Q2 2024. 53 funds tracked by Wall St. Rank hold FBIO as of Q4 2024.

  • SeaCrest Wealth Management reported no remaining Fortress Biotech position as of Q4 2024 after selling out during the quarter.
  • SeaCrest Wealth Management sold 12,000 Fortress Biotech shares in Q4 2024, an estimated $17.3K.
  • SeaCrest Wealth Management first reported a position in Fortress Biotech in Q2 2024 and held it in 2 quarters.
  • SeaCrest Wealth Management's Fortress Biotech position peaked at $18.8K in Q2 2024.
  • 53 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2024.

Based on SeaCrest Wealth Management's 13F filing for Q4 2024, filed 14 Jan 2025.